Literature DB >> 30062485

The intertwined fates of inflammation and coagulation in glioma.

Angela Cho1,2,3, Kelly J McKelvey1,2,3, Adrian Lee1,2,3, Amanda L Hudson4,5,6.   

Abstract

Inflammation and coagulation are two intertwined pathways with evolutionary ties being traced back to the hemocyte, a single cell type in invertebrates that has functions in both the inflammatory and coagulation pathways. These systems have functioned together throughout evolution to provide a solid defence against infection, damaged cells and irritants. While these systems work in harmony the majority of the time, they can also become dysregulated or corrupted by tumours, enhancing tumour proliferation, invasion, dissemination and survival. This review aims to give a brief overview of how these systems work in harmony and how dysregulation of these systems aids in the development and progression of cancer, using glioma as an example.

Entities:  

Mesh:

Year:  2018        PMID: 30062485     DOI: 10.1007/s00335-018-9761-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  119 in total

1.  Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion.

Authors:  Anthony Maraveyas; Camille Ettelaie; Hussein Echrish; Chao Li; Eric Gardiner; John Greenman; Leigh A Madden
Journal:  Blood Coagul Fibrinolysis       Date:  2010-07       Impact factor: 1.276

Review 2.  Signaling in innate immunity and inflammation.

Authors:  Kim Newton; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

3.  Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.

Authors:  Ying-Yu Ma; Xu-Jun He; Hui-Ju Wang; Ying-Jie Xia; Sheng-Li Wang; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Cancer Sci       Date:  2010-12-07       Impact factor: 6.716

4.  Venous thromboembolism (VTE) and glioblastoma.

Authors:  Shlomit Yust-Katz; Jacob J Mandel; Jimin Wu; Ying Yuan; Courtney Webre; Tushar A Pawar; Harshad S Lhadha; Mark R Gilbert; Terri S Armstrong
Journal:  J Neurooncol       Date:  2015-05-19       Impact factor: 4.130

5.  High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.

Authors:  Carole Colin; Brigitte Voutsinos-Porche; Isabelle Nanni; Frédéric Fina; Philippe Metellus; Dominique Intagliata; Nathalie Baeza; Corinne Bouvier; Christine Delfino; Anderson Loundou; Olivier Chinot; Tamara Lah; Janko Kos; Pierre-Marie Martin; L'Houcine Ouafik; Dominique Figarella-Branger
Journal:  Acta Neuropathol       Date:  2009-09-23       Impact factor: 17.088

6.  PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.

Authors:  R Auvergne; C Wu; A Connell; S Au; A Cornwell; M Osipovitch; A Benraiss; S Dangelmajer; H Guerrero-Cazares; A Quinones-Hinojosa; S A Goldman
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

7.  Thromboembolism in patients with high-grade glioma.

Authors:  J F Quevedo; J C Buckner; J L Schmidt; R P Dinapoli; J R O'Fallon
Journal:  Mayo Clin Proc       Date:  1994-04       Impact factor: 7.616

8.  The incidence and significance of thromboembolic complications in patients with high-grade gliomas.

Authors:  R Cheruku; E Tapazoglou; J Ensley; J A Kish; G D Cummings; M al-Sarraf
Journal:  Cancer       Date:  1991-12-15       Impact factor: 6.860

9.  Soluble fibrin inhibits lymphocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis and immunotherapy.

Authors:  John P Biggerstaff; Brandy Weidow; Judith Dexheimer; Gary Warnes; Jacqueline Vidosh; Shonak Patel; Michael Newman; Pretesh Patel
Journal:  Clin Appl Thromb Hemost       Date:  2007-12-26       Impact factor: 2.389

10.  Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.

Authors:  Michael Zhang; Gregor Hutter; Suzana A Kahn; Tej D Azad; Sharareh Gholamin; Chelsea Y Xu; Jie Liu; Achal S Achrol; Chase Richard; Pia Sommerkamp; Matthew Kenneth Schoen; Melissa N McCracken; Ravi Majeti; Irving Weissman; Siddhartha S Mitra; Samuel H Cheshier
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more
  4 in total

1.  Introduction to Mammalian Genome special issue: inflammation and immunity in cancer.

Authors:  Andreas Behren; Daniel Speidel; George Kollias; Viive M Howell
Journal:  Mamm Genome       Date:  2018-12       Impact factor: 2.957

2.  Combined Diagnostic Significance of Preoperative Serum β2-Microglobulin and Routine Blood Test in Patients with High-grade Glioma and Solitary Brain Metastasis.

Authors:  Liwen Li; Xiaomin Bu; Bin Wu; Shuyuan Zhang; Kai Jin; Liang Xia; Caixing Sun
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

3.  Differential effects of radiation fractionation regimens on glioblastoma.

Authors:  Kelly J McKelvey; Amanda L Hudson; Heather Donaghy; Shihani P Stoner; Helen R Wheeler; Connie I Diakos; Viive M Howell
Journal:  Radiat Oncol       Date:  2022-01-25       Impact factor: 3.481

4.  Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.

Authors:  Kelly J McKelvey; Amanda L Hudson; Ramyashree Prasanna Kumar; James S Wilmott; Grace H Attrill; Georgina V Long; Richard A Scolyer; Stephen J Clarke; Helen R Wheeler; Connie I Diakos; Viive M Howell
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.